Aim: The aim is to evaluate the additive role of outdoor play along with Atropine 0.01% in further controlling the progression of myopia in Indian children.

Methods: Children with progressive myopia were started on atropine 0.01% along with outdoor play. Children were divided into those who played outdoors for < 1 hour, 1 - 2 hours and > 2 hours per day. Effect of outdoor activity on progression in spherical power of myopia was correlated.

Results: 55 children with progressive myopia were included. 50.9% of children spent less than 1 hour daily in sunlight, 12.7% spent more than 2 hours outdoors. Myopia progression of 0.12 D was noted in children played >2 hours per day when compared to those who played less than one hour (0.87D). Those with family history showed a slower progression with increased outdoor play - 0.33D/year compared to - 0.68D/year in children who played less than 2 hours a day in sunlight.

Conclusion: Outdoor play has an additive effect along with atropine 0.01% in controlling the progression of myopia.

Keywords: Progressive Myopia; Outdoor Play; Atropine 0.01%

References

1. You QS., et al. “Prevalence of myopia in school children in greater Beijing: the Beijing childhood Eye study”. Acta Ophthalmologica 92.5 (2014): 398-406.
2. Vidhya., et al. “Safety and efficacy of reconstituted atropine 0.01% eye drops for Indian children with myopic progression”. Asian Journal of Ophthalmology (accepted for publication).
3. Morgan IG., et al. “Twoyear results from the Guangzhou outdoor activity longitudinal study (GOALS)”. ARVO Meet Abstracts 53 (2012): 27-35.
4. Jones LA., et al. “Parental history of myopia, sports and outdoor activities, and future myopia”. Investigative Ophthalmology and Visual Science 48 (2007): 3524-3532.
5. Chia A., et al. “Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops”. Ophthalmology 123 (2016): 391-399.
6. Jason Yam JC., et al. “Low‐concentration atropine for myopia progression (LAMP) study: a randomized, double‐blinded, placebo‐controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control”. Ophthalmology 126 (2019): 113-124.
7. Mihir Kothari and Vivek Rathod. “Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes”. Indian Journal of Ophthalmology 65 (2017): 1178-1181.
8. Rose KA., et al. “Outdoor activity reduces the prevalence of myopia in children”. Ophthalmology 115 (2008): 1279-1285.
9. Dirani M., et al. “Outdoor activity and myopia in Singapore teenage children”. British Journal of Ophthalmology 93 (2009): 997-1000.
10. Dong F., et al. “Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs”. Molecular Vision 17 (2011): 2824-2834.
11. Mehdizadeh M and Nowroozzadeh MH. “Outdoor activity and myopia”. Ophthalmology 116 (2009): 1229-1230.
12. Ojaimi E., et al. “Methods for a population-based study of myopia and other eye conditions in school children: the Sydney Myopia Study”. Ophthalmic Epidemiology 12.1 (2005): 59-69.

Citation

Citation: Kaushik Murali., et al. “Impact of Outdoor Play in Sunlight – An Additive Factor with Atropine 0.01% for Preventing Myopia Progression”. Acta Scientific Ophthalmology 3.2 (2020): 25-28.

Copyright

Copyright: © 2020 Kaushik Murali., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.